Guizhou Hu, MD, PhD

35
Guizhou Hu, MD, PhD Executive Vice President & Chief Scientific Officer BioSignia, Inc.

description

Guizhou Hu, MD, PhD. Executive Vice President & Chief Scientific Officer BioSignia , Inc. Agenda. What is Predictive Analytics? Predictive Analytics in life insurance An example of predictive model in life insurance underwriting - PowerPoint PPT Presentation

Transcript of Guizhou Hu, MD, PhD

Page 1: Guizhou Hu, MD, PhD

Guizhou Hu, MD, PhDExecutive Vice President & Chief Scientific Officer BioSignia, Inc.

Page 2: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Agenda

• What is Predictive Analytics?

• Predictive Analytics in life insurance

• An example of predictive model in life insurance underwriting

• Epidemiological research: the foundation of predictive models for life insurance underwriting

2

Page 3: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Predictive Analytics: What is it?

According to the Society of Actuaries, predictive modeling is:

“A process used in predictive analytics to create a statistical model of future behavior. Predictive analytics is the area of data mining concerned with

forecasting probabilities and trends. A predictive model is made up of a number of predictors, variable factors that are likely to influence or predict future

behavior. The end result is both a set of factors that predict, to a relatively high degree, the outcome of an event, as well as what that outcome will be. In

marketing, for example, a customer’s gender, age and purchase history might predict the likelihood of a future sale. To create a predictive model, data is

collected for the relevant factors, a statistical model is formulated, predictions are made and the model is validated. The model may employ a simple linear

equation or can be a complex neural network or genetic algorithm.”

3

Page 4: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Examples of Predictive Models

• LinkedIn connection recommendations• NCAA Tournament bracket tools• Amazon.com product recommendations• Framingham cardiovascular model

4

Page 5: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Attributes of Good Predictive Models

5

• How was the model built?– Empirically(objective)-based or non-empirically

(subjective) based– Based on single dataset or multiple data.

• How was the model validated?– External and internal validation– Two statistical features measure prediction model

performance:

• Calibration: How close the prediction matches the observed outcomes among different risk groups

• Discrimination: How much the model differentiates risk between individuals who die and those who live

Page 6: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Predictive Analytics in Life Insurance

• Target marketing• Fraud detection • Product design• Risk selection / underwriting

– Examples of predictive tools in underwriting:• Debit/credit scoring• Rules-engines• Financial credit scores (Deltoid)• MAT (BioSignia)• Lab scores (Exame One, CRL..)

6

Page 7: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Industry Forces Shaping Adoption of Predictive Analytics

Industry Drivers

Data availability

Technological advances

Pressure for growth in slow markets

Availability of analytic talent

Pressure for competitive advantage

7

Industry Reservations

“black box” perception

Limited validation

Competing internal priorities

Lack of IT resources

Regulatory concerns

Page 8: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Example of Predictive Analytics in life Insurance Underwriting

Mortality Assessment Technology (MAT)• How MAT was developed?

– Techniques

• Meta Analysis: summary of medical literature• Synthesis Analysis: integrate the multiple risk

factor into multivariate prediction equation.

– Contents: Primarily based on epidemiological research in medical fields

8

Page 9: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

How MAT Was Validated

9

• Data set– ~311,000 historically issued policies– Up to 9 years death claims– Apply MAT along with conventional underwriting guidelines to the

underwriting data• Specific questions:

– Does the predicted mortality from MAT closely match the observed mortality? (calibration)

– Does the risk class defined by MAT have greater mortality differentiation than conventional underwriting? (discrimination)

Page 10: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Validation Results

10

Conventional Classes

Class % PAE A/E

1 39% 0.5175 0.5299

2 30% 0.6302 0.6267

3 21% 0.7254 0.6767

4 10% 0.8609 0.8516

MAT output as predicted mortality

• Predicted mortality closely matches observed mortality• Conventional classification differentiates mortality by range

of 0.53-0.85

PAE

A/E Actual mortality expressed as A/E ratio of 2001 VBT

Page 11: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Validation Results

11

MAT ClassesClass % PAE A/E

1 39% 0.4766 0.46782 30% 0.6084 0.58633 21% 0.7605 0.78084 10% 1.0125 0.9130

• Once again, predicted mortality closely matches observed mortality

• MAT differentiates mortality more than Conventional– MAT range (0.47-0.91)– Conventional range (0.52-0.85)

• MAT-defined best class has mortality 10% lower than conventionally-defined best class

Page 12: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Epidemiological Research

12

• Epidemiological research is the foundation of predication analytics for life insurance underwriting

• Selected epidemiology studies carried out by scientists at BioSignia– Predicting mortality by:

• Clinical lab tests

• Cognitive function tests

• Social factors

Page 13: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Clinical Lab Tests and Mortality

13

• Study population

– NHANES III: 4,610 deaths occurred during the 240,428 person-year study period

– Life insurance data: 837 death claims in 1.4 million person-year study period

Page 14: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

AST and Mortality

14

NHANES III

Life Insurance

Good Predictor?

Page 15: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

ALT and Mortality

15

NHANES III

Life Insurance

Good Predictor?

Page 16: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

GGT and Mortality

16

NHANES III

Life Insurance

Good Predictor?

Page 17: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Blood Total Bilirubin and Mortality

17

NHANES III

Life Insurance

Good Predictor?

Page 18: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Alkaline Phosphatase and Mortality

18

NHANES III

Life Insurance

Good Predictor?

Page 19: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

BUN and Mortality

19

NHANES III

Life Insurance

Good Predictor?

Page 20: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Blood Creatinine and Mortality

20

NHANES III

Life Insurance

Good Predictor?

Page 21: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Blood Albumin and Mortality

21

NHANES III

Life Insurance

Good Predictor?

Page 22: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Cognitive Function Tests and Mortality

22

• Study Population: Health Retirement Study (HRS)– 8,268 deaths occurred– 245,000 person-year study period

Page 23: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Word Recall

23

• The interviewer read a list of 10 nouns (e.g., lake, car, army, etc.) to the respondent, and asked the respondent to recall as many words as possible from the list in any order.

% of individuals with score of <=4, by age and gender

Page 24: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Series 7

24

• The interviewer asked the respondent to subtract 7 from 100, and continue subtracting 7 from each subsequent number for a total of five trials.

% of individuals with score of <=2 by age and gender

Page 25: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Age, Gender and Smoking-adjusted Hazard Ratios of WR by Age Group in HRS

25

Age<60 Age 60-69

Age 70-79 Age >=80

Lower WR score, higher mortality. Impact decreases as age increases

Page 26: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Age, Gender, and Smoking-adjusted Hazard Ratios of SER7 by Age Group in HRS

26

Age<60 Age 60-69

Age 70-79 Age >=80

Page 27: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Social Factors and Mortality

27

• Study Population: NHANES III– 5,408 deaths occurred – 280,000 person-years study period

Page 28: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Education and Mortality

28

• Hazard ratios of education level in age- and gender-adjusted Cox model, on all-cause mortality

Page 29: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Employment and Mortality

29

• Hazard ratios for employment

Page 30: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Marital Status and Future Mortality

30

• Hazard ratio for marital status

Page 31: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Close with Friends and Family

31

• “How often do you get together with friends or relatives; I mean things like going out together or visiting in each other’s homes?”

Page 32: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Socialization with Neighbors

32

• “How often do you visit with any of your other neighbors, either in their homes or in your own?”

Page 33: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Church Attendance

33

• “How often do you attend church or religious services?”

Page 34: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Belong to any Social Organization

34

• “Do you belong to any clubs or organizations such as church groups unions, fraternal or athletic groups, or school groups?”

Page 35: Guizhou Hu, MD, PhD

© BioSignia, Inc. 2012 CONFIDENTIAL DO NOT COPY OR DISTRIBUTE WITHOUT PERMISSION OF BIOSIGNIA INC.

Summary

35

• Predictive analytics

– Broad fields with various applications

– Various models in the marketplace for life underwriting

• Validation of the model is difficult, but important

• Epidemiological research and literature support are the foundation of predictive analytics